Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1).
21 CFR 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1)., “Specific requirements on content and format of labeling for human prescription drug and biological products…”, is a CFR section of 21 CFR Part 201, Subpart B—Labeling Requirements for Prescription Drugs and/or Insulin; in force.
https://ontology.bommaritollc.com/id/01a0f094-c333-77df-9523-a7dc0b2a5cb0
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 201.57 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1)en |
| schema:url | |
| skos:prefLabel | 21 CFR 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1).en |
Related
Cited by (14)eli:cites
- 21 CFR 201.100 Prescription drugs for human use.
- 21 CFR 201.21 Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.
- 21 CFR 201.22 Prescription drugs containing sulfites; required warning statements.
- 21 CFR 201.56 Requirements on content and format of labeling for human prescription drug and biological products.
- 21 CFR 201.58 Waiver of labeling requirements.
- 21 CFR 201.80 Specific requirements on content and format of labeling for human prescription drug and biological products; older drugs not described in § 201.56(b)(1).
- 21 CFR 207.1 What definitions and interpretations of terms apply to this part?
- 21 CFR 208.20 Content and format of a Medication Guide.
- 21 CFR 251.13 Labeling of eligible prescription drugs.
- 21 CFR 314.50 Content and format of an NDA.
- 21 CFR 314.70 Supplements and other changes to an approved NDA.
- 21 CFR 343.80 Professional labeling.
- 21 CFR 601.12 Changes to an approved application.
- 21 U.S.C. 356 Expedited approval of drugs for serious or life-threatening diseases or conditions